79
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Effects of IL-6 Variants in Multiple Myeloma: Growth Inhibition and Induction of Apoptosis in Primary Cells

, , , , , & show all
Pages 2369-2375 | Published online: 01 Jul 2009

  • Jagannath, S., Barlogie, B., Dicke, K., Alexanian, R., Zagars, G., Cheson, B., Le Maistre, F.C., Smallwood, L., Pruitt, K. and Dixon, D.O. (1990) "Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors", Blood 76, 1860 - 1866
  • Gahrton, G., Tura, S., Ljungman, P., Belanger, C., Brant, L., Cavo, M., Facon, T., Granena, A., Gore, M., Gratwohl, A., Lowenberg, B., Nikoskelainen, J., Reiffers, J.J., Samson, D., Verdonck, L. and Volin, L. (1991) "Allogeneic bone marrow transplantation in multiple myeloma", New England Journal of Medicine 325, 1267 - 1273
  • Anderson, K.G., Andersen, J., Soiffer, R., Freedman, A.S., Rabinowe, S.N., Robertson, M.J., Spector, N., Blanke, K., Murray, C., Freeman, A., Coral, F., Marcus, K.C., Mauch, P., Nadler, L.M. and Ritz, J. (1993) "Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma", Blood 82, 2568 - 2576
  • Latreille, J., Barlogie, B., Johnston, J., Drewinco, B. and Alexanian, R. (1982) "Ploidy and proliferative characteristics in monoclonal gammopathies", Blood 59, 43 - 51
  • Boccadoro, M., Marmont, F., Tribalto, M., Fossati, G., Redoglia, V., Battaglio, S., Massaia, M., Gallamini, A., Comotti, B., Barbui, T., Campobasso, N., Dammacco, F., Cantonetti, M., Petrucci, M.T., Mandelli, F., Resegotti, L. and Pileri, A. (1989) "Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis", Journal Clinical Oncology 7, 119 - 125
  • Zhang, X.G., Klein, B. and Bataille, R. (1989) "Interleukin-6 is a potent myeloma cell growth factor in patients with aggressive multiple myeloma", Blood 74, 11 - 13
  • Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. and Barut, B.A. (1989) "Response patterns of purified myeloma cells to hematopoietic growth factors", Blood 73, 1915 - 1924
  • Klein, B., Zhang, X., Jourdan, M., Content, J., Houssian, F., Aarden, L., Piechaczyk, M. and Battaille, R. (1989) "Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6", Blood 73, 517 - 526
  • Vink, A., Coulie, P., Warnier, G., Renauld, J.C., Stevens, M., Donckers, D. and Van Snick, J. (1990) "Mouse plasmacytomas growth in vivo : enhancement by interleukin-6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor", Journal Experimental Medicine 172, 997 - 1002
  • Bataille, R., Barlogie, B., Yang Lu, Z., Rossi, J.F., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J. and Klein, B. (1995) "Biological effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma", Blood 86, 685 - 691
  • Drewinko, B., Alexanian, R., Boyer, H., Barlogie, B. and Rubinow, S.I. (1981) "The growth fraction of human myeloma cells", Blood 57, 333 - 338
  • Hamilton, M.S., Barker, H.F., Ball, J., Drew, M., Abbot, S.D. and Franklin, I.M. (1991) "Normal and neoplastic human plasma cells express Bcl-2 antigen", Leukemia 5, 768 - 771
  • Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Retting, M., Berenson, J., Krajewski, S., Reed, J.C. and Lichtenstein, A. (1998) "Bcl-X expression in multiple myeloma: possible indicator of chemoresistance", Cancer Research 58, 256 - 262
  • Yonehara, S., Ishii, A. and Yonehara, M. (1989) "A cell-killing monoclonal antibody (anti Fas) to a cell surface antigen co-downregulate with the receptor of tumor necrosis factor", Journal of Experimental Medicine 169, 1747 - 1751
  • Okamura, T., Masuda, M., Arai, Y., Ishida, C., Shudou, K. and Mizoguchi, H. (1998) "All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266Bl", Experimental Hematology 26, 501 - 506
  • Savino, R., Lahm, A., Salvati, A.L., Ciapponi, L., Sporeno, E., Altamura, S., Paonessa, G., Toniatti, C. and Ciliberto, G. (1994) "Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp-130 activation", EMBO Journal 13, 1357 - 1367
  • Savino, R., Ciapponi, L., Lahm, A., Demartis, A., Cabibbo, A., Toniatti, C., Delmastro, P., Altamura, S. and Ciliberto, G. (1994) "Rational design of a receptor super-antagonist of human interleukin-6", EMBO Journal 13, 5863 - 5870
  • Sporeno, E., Savino, R., Ciapponi, L., Paonessa, G., Cabibbo, A., Lahm, A., Pulkki, K., Sun, R.X., Toniatti, C., Klein, B. and Ciliberto, G. (1996) "Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells", Blood 87, 4510 - 4519
  • Petrucci, M.T., Ricciardi, M.R., Ariola, C., Gregorj, C., Ribersani, M., Savino, R., Ciliberto, G. and Tafuri, A. (1998) "Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1", Annals of Hematology 77, 13 - 18
  • Demartis, A., Bernassola, F., Savino, R., Melino, G. and Ciliberto, G. (1996) "Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death", Cancer Research 56, 4213 - 4218
  • Zhang, X.G., Gaillard, J.P., Robillard, N., Lu, Z.Y., Gu, Z.J., Jourdan, M., Boiron, J.M., Battaille, R. and Klein, B. (1994) "Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma", Blood 83, 3654 - 3663
  • Paonessa, G., Graziani, R., De Serio, A., Savino, R., Ciapponi, L., Lahm, A., Salvati, A.L., Toniatti, C. and Ciliberto, G. (1995) "Two distinct and independent sites on IL-6 trigger gp-130 dimer formation and signaling", EMBO Journal 14, 1942 - 1951
  • Tafuri, A., De Felice, L., Goodacre, A., Fenu, S., Petrucci, M.T., Valentini, T., Alimena, G., Petti, M.C., Meloni, G. and Mandelli, F. (1995) "Il-3 priming in acute myeloid leukemia patients", British Journal of Haematology 91, 234 - 244
  • Darzynkiewicz, Z., Everson, D.P., Staiano-Coico, L., Sharpless, T.K. and Melamed, M.R. (1979) "Relationship between RNA content and progression of lymphocytes through the S phase of the cell cycle", Proceedings of the National Academy of Science USA 76, 358 - 362
  • Hiddemann, W., Schumann, J., Andreff, M., Barlogie, B., Herman, C.J., Leif, R.C., Mayall, B.H., Murphy, R.F. and Sandberg, A.A. (1984) "Convention on nomenclature for DNA cytometry", Cytometry 5, 445 - 446
  • Andreff, M., Darzynkiewicz, Z., Sharpless, T.K. and Melamed, M.R. (1980) "Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA", Blood 55, 282 - 293
  • Lemoli, R.M., Tafuri, A., Fortuna, A., Petrucci, M.T., Ricciardi, M.R., Catani, L., Rondelli, R., Fogli, M., Leopardi, G., Ariola, C. and Tura, S. (1997) "Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor", Blood 89, 1189 - 1196
  • Yang Lu, Z., Brailly, H., Wijdenes, J., Bataille, R., Rossi, J.F. and Klein, B. (1995) "Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatment", Blood 86, 3123 - 3127
  • Barut, A.B., Zon, L.I., Cochran, M.K., Paul, S.R., Chauhan, D., Mohrbacher, A., Fingeroth, J. and Anderson, K.C. (1992) "Role of interleukin 6 in the growth myeloma-derived cell lines", Leukemia Research 16, 951 - 959

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.